Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Return on Invested Capital (2019)

Historic Return on Invested Capital for Allogene Therapeutics (ALLO) over the last 2 years, with Q3 2020 value amounting to 0.22%.

  • Allogene Therapeutics' Return on Invested Capital changed N/A to 0.22% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.22%, marking a year-over-year change of. This contributed to the annual value of 0.59% for FY2024, which is N/A changed from last year.
  • As of Q3 2020, Allogene Therapeutics' Return on Invested Capital stood at 0.22%.
  • Allogene Therapeutics' Return on Invested Capital's 5-year high stood at 0.22% during Q3 2020, with a 5-year trough of 0.36% in Q1 2020.